We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Sysmex Presents Next-Generation Diagnostic Solutions at ADLM 2026

By LabMedica International staff writers
Posted on 28 Jul 2026

Sysmex America is participating in the ADLM 2026 Clinical Lab Expo, taking place July 28–30 in Anaheim, California. More...

At booth 2701, the company is presenting diagnostic solutions spanning hematology, hemostasis, urinalysis, flow cytometry, and laboratory informatics, with a focus on improving efficiency, diagnostic confidence, and the quality of patient results.

Leading the showcase is the next-generation XR-Series hematology portfolio, which builds on the company’s XN-Series platform with higher throughput, enhanced analytics, advanced three-dimensional scattergram technology, and integration with complementary workflow solutions. The XR-1000 processes up to 110 samples per hour and combines advanced parameters with onboard decision rules designed to standardize and simplify hematology testing.

For higher-volume laboratories, Sysmex is featuring the modular XR-9000 system, which is designed to increase throughput while minimizing manual touchpoints. The company is also presenting the DIFF-Line by CellaVision for blood-cell differential workflows and Sentinel SENTiFIT systems for high-throughput fecal occult blood and calprotectin testing. Some of these products are not available for sale in all countries.

Another highlight is the new Sysmex CentralOps Command Center, a customizable informatics solution that consolidates data from different Sysmex systems, provides real-time laboratory monitoring, and uses configurable rules to support sample processing and workflow management. The platform is intended to help laboratories identify operational insights and coordinate more efficient decision-making from a centralized interface. CentralOps is not currently available for sale.

In hemostasis, Sysmex is showcasing the new CN-9000 configuration for busy, high-volume laboratories. The system combines high throughput with continuous sample loading and automated rerun and reflex testing to streamline operations. The broader CN-Series consolidates routine and specialized testing on an automated platform, while the compact CA-600 Series is designed for lower-volume laboratories performing routine hemostasis assays.

The company’s urinalysis display includes the UN-Series, an automated platform that integrates urine chemistry, particle counting, sediment analysis, and confirmatory digital imaging. The system is designed to increase walkaway time while supporting accurate and efficient urine testing.

Sysmex is also presenting flow cytometry solutions, including the PS-10 sample preparation system and the research-use-only XF-1600 10-color flow cytometer. The XF-1600 combines fluidics and optical technologies to support high detection sensitivity at elevated sample flow rates. Visitors can additionally explore a portfolio of more than 200 single-color analyte-specific antibody reagents for flow cytometry applications.

Through live demonstrations and discussions with laboratory professionals, Sysmex is highlighting how specialty automation and connected informatics can help laboratories manage growing workloads, reduce manual intervention, and prepare for evolving diagnostic demands.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.